Geneos Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$410K Sell
780
-747
-49% -$392K 0.01% 773
2025
Q1
$968K Buy
1,527
+837
+121% +$531K 0.01% 669
2024
Q4
$492K Buy
690
+3
+0.4% +$2.14K 0.02% 596
2024
Q3
$722K Sell
687
-119
-15% -$125K 0.03% 474
2024
Q2
$847K Sell
806
-40
-5% -$42K 0.04% 390
2024
Q1
$814K Sell
846
-18
-2% -$17.3K 0.04% 388
2023
Q4
$759K Sell
864
-42
-5% -$36.9K 0.04% 379
2023
Q3
$746K Sell
906
-102
-10% -$83.9K 0.04% 374
2023
Q2
$724K Sell
1,008
-29
-3% -$20.8K 0.04% 382
2023
Q1
$852K Sell
1,037
-49
-5% -$40.3K 0.05% 326
2022
Q4
$784K Sell
1,086
-37
-3% -$26.7K 0.05% 321
2022
Q3
$773K Buy
1,123
+8
+0.7% +$5.51K 0.05% 304
2022
Q2
$663K Sell
1,115
-62
-5% -$36.9K 0.03% 422
2022
Q1
$822K Sell
1,177
-30
-2% -$21K 0.04% 415
2021
Q4
$762K Sell
1,207
-23
-2% -$14.5K 0.03% 470
2021
Q3
$702K Sell
1,230
-191
-13% -$109K 0.03% 486
2021
Q2
$829K Sell
1,421
-138
-9% -$80.5K 0.03% 421
2021
Q1
$750K Sell
1,559
-52
-3% -$25K 0.02% 518
2020
Q4
$767K Buy
1,611
+1,265
+366% +$602K 0.03% 427
2020
Q3
$198K Buy
346
+5
+1% +$2.86K 0.01% 689
2020
Q2
$208K Sell
341
-196
-36% -$120K 0.01% 658
2020
Q1
$245K Buy
537
+20
+4% +$9.13K 0.02% 552
2019
Q4
$193K Hold
517
0.01% 712
2019
Q3
$141K Hold
517
0.01% 773
2019
Q2
$161K Hold
517
0.01% 737
2019
Q1
$212K Buy
517
+7
+1% +$2.87K 0.01% 621
2018
Q4
$184K Sell
510
-40
-7% -$14.4K 0.01% 631
2018
Q3
$222K Hold
550
0.01% 604
2018
Q2
$189K Sell
550
-17
-3% -$5.84K 0.01% 581
2018
Q1
$195K Hold
567
0.02% 548
2017
Q4
$213K Hold
567
0.02% 514
2017
Q3
$253K Sell
567
-1
-0.2% -$446 0.03% 448
2017
Q2
$278K Sell
568
-10
-2% -$4.89K 0.03% 417
2017
Q1
$223K Sell
578
-11
-2% -$4.24K 0.02% 456
2016
Q4
$216K Hold
589
0.03% 442
2016
Q3
$236K Buy
589
+11
+2% +$4.41K 0.03% 410
2016
Q2
$207K Hold
578
0.03% 432
2016
Q1
$234K Buy
+578
New +$234K 0.04% 400